- Home
- CVR vs BOLT Comparison
CVR vs BOLT Comparison
Compare CVR & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVR | BOLT |
|---|---|---|
| Founded | 1920 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 10.5M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CVR | BOLT |
|---|---|---|
| Price | $13.57 | $3.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 2.7K | ★ 19.7K |
| Earning Date | 01-01-0001 | 06-29-2026 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $26,986,627.00 | $7,695,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.07 |
| 52 Week Low | $8.15 | $0.26 |
| 52 Week High | $15.00 | $7.35 |
Technical Indicators
Market Signals| Indicator | CVR | BOLT |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 32.11 |
| Support Level | $13.32 | $0.27 |
| Resistance Level | $14.47 | $5.45 |
| Average True Range (ATR) | 0.51 | 0.33 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 18.29 | 0.00 |
Price Performance
Historical ComparisonAbout CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.